CY1115392T1 - PHARMACEUTICAL COMPOSITIONS INCLUDING LANTHANE UNITS - Google Patents
PHARMACEUTICAL COMPOSITIONS INCLUDING LANTHANE UNITSInfo
- Publication number
- CY1115392T1 CY1115392T1 CY20141100568T CY141100568T CY1115392T1 CY 1115392 T1 CY1115392 T1 CY 1115392T1 CY 20141100568 T CY20141100568 T CY 20141100568T CY 141100568 T CY141100568 T CY 141100568T CY 1115392 T1 CY1115392 T1 CY 1115392T1
- Authority
- CY
- Cyprus
- Prior art keywords
- lanthanum compound
- resulting
- mixture
- units
- lanthanum
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Αυτή η εφεύρεση σχετίζεται με μία σύνθεση λανθανίου που μπορεί να μασηθεί που περιλαμβάνει μια φαρμακευτικά αποτελεσματική ποσότητα μιας ένωσης λανθανίου και τουλάχιστον ένα φαρμακευτικά αποδεκτό έκδοχο που μπορεί να μασηθεί. Αυτή η εφεύρεση σχετίζεται επίσης με μία φαρμακευτική σύνθεση σε ταμπλέτα ή σε σκόνη που περιλαμβάνει μία φαρμακευτικά αποτελεσματική ποσότητα ένωσης λανθανίου που παράγεται από μία διαδικασία που περιλαμβάνει τα εξής στάδια: a) ανάμιξη της ένωσης λανθανίου και τουλάχιστον ενός φαρμακευτικά αποδεκτού εκδόχου σε ένα αναμικτήρα ώστε να σχηματιστεί ένα μίγμα, ή b) ανάμιξη της σκόνης της ένωσης λανθανίου και εκδόχων, συμπίεση του συνδυασμού που προκύπτει σε ένα πρεσαριστό υλικό ή συμπίεση με κύλινδρο του συνδυασμού που προκύπτει σε ένα πλεκτό υλικό, και άλεση του παρασκευασμένου υλικού σε μίγμα ελεύθερης ροής και c) συμπίεση του μίγματος που προκύπτει σε ταμπλέτα ή γέμισμα του μίγματος που προκύπτει μέσα σε ένα κατάλληλο δοχείο.This invention relates to a chewable lanthanum composition comprising a pharmaceutically effective amount of a lanthanum compound and at least one pharmaceutically acceptable chewable excipient. This invention also relates to a tablet or powder pharmaceutical composition comprising a pharmaceutically effective amount of a lanthanum compound produced by a process comprising the following steps: a) admixing the lanthanum compound and at least one pharmaceutically acceptable excipient in a mixer to a mixture is formed, or b) mixing the powder of the lanthanum compound and excipients, compressing the resulting combination into a pressed material or rolling the combination resulting in a knit material, and milling the prepared material into a free flowing mixture; and c) compressing the resulting mixture into a tablet or filling the resulting mixture into a suitable container.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49756003A | 2003-08-26 | 2003-08-26 | |
| US51707803A | 2003-11-05 | 2003-11-05 | |
| EP20100151270 EP2172205B1 (en) | 2003-08-26 | 2004-08-26 | Pharmaceutical formulation comprising lanthanum compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1115392T1 true CY1115392T1 (en) | 2017-01-04 |
Family
ID=58461552
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20141100568T CY1115392T1 (en) | 2003-08-26 | 2014-07-28 | PHARMACEUTICAL COMPOSITIONS INCLUDING LANTHANE UNITS |
| CY20151100309T CY1117082T1 (en) | 2003-08-26 | 2015-03-30 | PHARMACEUTICAL COMPOSITION INCLUDING LANTHANI UNITS |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20151100309T CY1117082T1 (en) | 2003-08-26 | 2015-03-30 | PHARMACEUTICAL COMPOSITION INCLUDING LANTHANI UNITS |
Country Status (1)
| Country | Link |
|---|---|
| CY (2) | CY1115392T1 (en) |
-
2014
- 2014-07-28 CY CY20141100568T patent/CY1115392T1/en unknown
-
2015
- 2015-03-30 CY CY20151100309T patent/CY1117082T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1117082T1 (en) | 2017-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1118211T1 (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING LANTHANE UNITS | |
| CY1115652T1 (en) | DOSAGE FORM THAT CONTAINS TWO ACTIVE MEDICINAL MIXING INGREDIENTS IN DIFFERENT NATURAL FORMS | |
| CL2010001275A1 (en) | Method for producing a compacted intermediate product of bibw 2992 ma2 comprising a stage of compaction by rollers of bibw 2992 ma2 or optionally in a premix with 0-1.0% lubricant in a free fall or flip mixer and a stage of sifting; compacted intermediate product; compressed. | |
| CO5190672A1 (en) | COMPOSITION FOR ORAL DOSAGE, INSTANT DISSOLUTION | |
| DK1157037T3 (en) | G-CSF-conjugates | |
| CY1115825T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING LEVETIRAKETAM AND THEIR PREPARATION PROCEDURE | |
| AR022008A1 (en) | A COMPOSITION OF CONTROLLED GALANTAMINE RELEASE, A PROCESS FOR THE PREPARATION OF THE SAME, AND THE USE OF SUCH COMPOSITION FOR THE PREPARATION OF A MEDICINAL PRODUCT | |
| EA200800931A1 (en) | SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR INTRODUCTION ONCE AGAIN A DAY, CONTAINING PREGABALIN, A MATERIAL FORMING AGENT AND A SMELLING AGENT | |
| WO2006138608A3 (en) | Pharmaceutical compositions and use thereof | |
| AR054222A1 (en) | PROCEDURE TO PRODUCE A PROTECTED PHARMACEUTICAL FORM BEFORE FRAUDULENT USE | |
| BR0209489A (en) | Pharmaceutical Compositions | |
| EA200901393A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING GESTAGENES AND / OR ESTROGENS AND 5 METHYL- (6S) -TETRAHYDROPHOLATE | |
| EA200801926A1 (en) | TABLETS OF PARACETAMOL WITH FAST DELIVERY | |
| MX2008001645A (en) | Oral pharmaceutical suspension compositions of fexofenadine. | |
| MXPA04005104A (en) | Dosage regimen and pharmaceutical composition for emergency contraception. | |
| TW200501965A (en) | Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle | |
| IL164440A0 (en) | New pharmaceutical composition containing fibanserin polymorph a | |
| AR045719A1 (en) | PHARMACEUTICAL FORMULATION THAT INCLUDES SODIUM LEVOTIROXIN, MICROCRYSTALLINE CELLULOSE AND PREGELATINIZED ALMIDON; USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PROCESS TO PREPARE THIS FORMULATION | |
| CL2004001843A1 (en) | COMBINATION OF (A) AT LEAST A 2,5-DIHYDROBENCENOSULPHONIC DERIVATIVE, AS CALCIUM DOBEYLATE, ETHAMSYLATE AND PERSILATE, AND (B) AT LEAST A MODULATOR OF POTASSIUM CHANNELS, PHARMACEUTICAL COMPOSITION CONTAINING AND USE AS A MEDICATION IN PROFILA | |
| EA200700203A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING GABAPENTIN | |
| MY142082A (en) | Substituted pyrroles, compositions containing them, method of manufacture and use | |
| CY1115392T1 (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING LANTHANE UNITS | |
| CY1108785T1 (en) | STABLE MEDICINAL GEL DICLOFENAC NA | |
| MXPA02010828A (en) | Pharmaceutical composition in capsules comprising a non-steroidal anti-inflammatory and an opiate analgesic for handling pain. | |
| BRPI0508767A (en) | composition having improved palatability, sieved freeze-dried particles, free-flowing compressible powder-like freeze-dried particles, process for making them, improved palatability pharmaceutical compositions, method for making them and method for making tablets |